Functional activation of integrin αvβ3 in tumor cells expressing membrane-type 1 matrix metalloproteinase

International Journal of Cancer

Volumn 86, Issue 1, 2000, Pages 15-23

  Deryugina, Elena I ^a   Bourdon, Mario A ^a   Jungwirth, Karli ^a   Smith, Jeffrey W ^b   Strongin, Alex Y ^a,b  

^a La Jolla Institute for Experimental Medicine   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; INTEGRIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN MCF 7; CELL TRANSFORMATION; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; TUMOR CELL;

ANTIGENS, CD; BINDING SITES; BREAST NEOPLASMS; CELL ADHESION; CELL MOVEMENT; ENZYME ACTIVATION; ENZYME PRECURSORS; GELATINASES; HUMANS; INTEGRIN BETA3; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; PHENOTYPE; PLATELET MEMBRANE GLYCOPROTEINS; PRECIPITIN TESTS; RECEPTORS, VITRONECTIN; TRANSFECTION;

EID: 0034088799     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B     Document Type: Article

References (21)

1. BROOKS, P.C., STROMBLAD, S., SANDERS, L.C., VON SCHALSCHA, T.L., AIMES, R.T., STETLER-STEVENSON, W.G., QUIGLEY, J.P. and CHERESH, D.A., Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell, 85, 683-693 (1996).
2. BROOKS, P.C., SILLETTI, S., VON SCHALSCHA, T.L. FRIEDLANDER, M. and CHERESH, D.A., Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell, 92, 391-400 (1998).
3. CHERESH, D.A., SMITH, J.W., COOPER, H.M. and QUARANTA, V., A novel vitronectin receptor integrin (αvβx) is responsible for distinct adhesive properties of carcinoma cells. Cell, 57, 59-69 (1989).
4. DELCOMMENNE, M. and STREULI, C.H., Control of integrin expression by extracellular matrix. J. Biol. Chem., 270, 26794-26801 (1995).
5. DERYUGINA, E.I., STRONGIN, A., Y.U, C. and BOURDON, M., A novel monoclonal antibody, L1A3, is directed to the functional site of the αv integrin subunit. Hybridoma, 15, 279-288 (1996).
6. DERYUGINA, E.I., BOURDON, M.A., LUO, G-X., REISFELD, R.A. and STRONGIN, A., Matrix metalloproteinase-2 activation modulates glioma cell migration. J. Cell Sci., 110, 2473-2482 (1997).
7. DERYUGINA, E.I., BOURDON, M.A., REISFELD, R.A. and STRONGIN, A., Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res., 58, 3743-3750 (1998).
8. GINSBERG, M.H., DU, X. and PLOW, E.F., Inside-out integrin signalling. Curr. Opin. Cell Biol., 4, 766-771 (1992).
9. HUGHES, P.E. and PFAFF, M., Integrin affinity modulation. Trends Cell Biol. 8, 359-364 (1998).
10. LIN, E.C., RATNIKOV, B.I., TSAI, P.M., CARRON, C.P., MYERS, D.M., BARBAS, C.F. and SMITH, J.W., Identification of a region in the integrin beta3 subunit that confers ligand binding specificity. J. Biol. Chem., 272, 23912-23920 (1997).
11. MENASHI, S., DEHEM, M., SOULIAC, I., LEGRAND, Y. and FRIDMAN, R., Density-dependent regulation of cell-surface association of matrix metalloproteinase-2 (MMP-2) in breast-carcinoma cells. Int. J. Cancer, 75, 259-265 (1998).
12. NAKAHARA, H., HOWARD, L., THOMPSON, E.W., SATO, H., SEIKI, M., YEH, Y. and CHEN, W.T., Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadipodia is required for cell invasion. Proc. Natl. Acad. Sci. USA., 94, 7959-7964 (1997).
13. PELLETIER, A.J., KUNICKI, T. and QUARANTA, V., Activation of the integrin αvβ3 involves a discrete cation-binding site that regulates conformation. J. Biol. Chem., 271, 1364-1370 (1996).
14. RUOSLAHTI, E., Integrin signaling and matrix assembly. Tumor Biol., 17, 117-124 (1996).
15. SATO, H., TAKINO, T., OKADA, Y., CAO, J., SHINAGAWA, A., YAMAMOTO, E. and SEIKI, M., A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature, 370, 61-65 (1994).
16. SEIKI, M., Membrane-type matrix metalloproteinases. APMIS, 107, 137-143 (1999).
17. STRONGIN, A., MARMER, B., GRANT, G. and GOLDBERG, G.I., Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem., 268, 14033-14039 (1993).
18. STRONGIN, AY., COLLIER, I., BANNIKOV, G., MARMER, B.L., GRANT, G.A. and GOLDBERG, G.I., Mechanism of cell surface activation of the 72 kD type IV collagenase: Isolation of the activated form of the membrane metalloproteinase. J. Biol. Chem., 270, 5331-5338 (1995).
19. TAKAGI, J., KAMATA, T., MEREDITH, J., PUZON-MCLAUGHLIN, W. and TAKADA, Y., Changing ligand specificity of alphavbeta1 and alphavbeta3 integrins by swapping a short diverse sequence of the beta subunit. J. Biol. Chem., 272, 19794-19800 (1997).
20. VARNER, J.A. and CHERESH, D.A., Integrins and cancer. Curr. Opin. Cell Biol., 8, 724-730 (1996).
21. WAYNER, E.A., ORLANDO, R. and CHERESH, D.A., Integrins αvβ3 and αvβ5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface. J. Cell Biol. 113, 919-929 (1991).